MedTrace Logo

Effects of Fat Emulsions on PNALD and Oxidative Stress in Premature Infants

NCT04277923 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2020-02-20

No results posted yet for this study

Summary

Abnormal liver function or cholestasis is the result of multiple factors, include low birth weight, smaller than gestational age, preterm birth, infection, lipid emulsion (LE) in parenteral nutrition (PN), insufficient enteral nutrition (EN) etc. Most are inevitable, but the LEs in PN can be selected. So the investigators compare two LEs, and want to see if the SMOF LE can improve hepatic index in preterm infants.

Conditions

  • Preterm Infant

Interventions

DRUG

SMOFlipid

the lipid of all-in-one is less than 4g/kg.d

DRUG

Lipofundin

the lipid of all-in-one is less than 4g/kg.d

Sponsors & Collaborators

  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Ying Wang, Phd · Xin Hua Hospital, School of Medicine, Shanghai Jiao Tong University,China

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-29
Primary Completion
2021-08-31
Completion
2021-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04277923 on ClinicalTrials.gov